• ABOUT US
    ▼
    • Our Vision
    • Leadership Team
  • OUR RESEARCH
    ▼
    • Our Approach
    • Publications
    • Conferences
  • PROGRAMS
    ▼
    • Pipeline
    • VIS649 Sibeprenlimab
    • VIS171
    • VIS513
  • FOR PATIENTS
    ▼
    • Clinical Trials
    • IgA Nephropathy
  • CAREERS
    ▼
    • Open Positions & Benefits
    • Our Culture
    • Co-op program
  • Contact

Visterra

We Bring Better Biologics to Life

  • ABOUT US
    • Our Vision
    • Leadership Team
  • OUR RESEARCH
    • Our Approach
    • Publications
    • Conferences
  • PROGRAMS
    • Pipeline
    • VIS649 Sibeprenlimab
    • VIS171
    • VIS513
  • FOR PATIENTS
    • Clinical Trials
    • IgA Nephropathy
  • CAREERS
    • Open Positions & Benefits
    • Our Culture
    • Co-op program
  • Contact

Conferences

Conferences

A Novel IL-2 Mutein Selectively Expands Regulatory T Cells and Prolongs Skin Graft Survival

June 4, 2022 | American Transplant Congress
Orhan Efe et al.

A Novel IL-2 Mutein Selectively Expands Regulatory T Cells and Prolongs Skin Graft Survival

Orhan Efe, Thiago J Borges, Rodrigo B Gassen, Leela Morena, Ayman Al Jurdi, Isadora T Lape, Gregory J Babcock, Joren C Madsen, Leonardo V Riella

Selective Regulatory T Cell Expansion by Novel IL-2 Mutein Prolongs Skin Transplant Survival

June 4, 2021 | American Transplant Congress
Thiago J Borges et al.

Selective Regulatory T Cell Expansion by Novel IL-2 Mutein Prolongs Skin Transplant Survival

Thiago J Borges, Orhan Efe, Rodrigo B Gassen, Ayman Al Jurdi, Isadora T Lape, Gregory J Babcock, Scott M Carlson, Joren C Madsen, Leonardo V Riella

>SEE POSTER

Targeting C5aR1 for the Treatment of ANCA-associated Vasculitis

March 3, 2020 | Festival of Biologics

Targeting C5aR1 for the Treatment of ANCA-associated Vasculitis

Greg Babcock

Monovalent IgGs as a Tool for Characterizing Antibody Binding and Function

January 20, 2020 | Peptalk
Booth, et. al.

Monovalent IgGs as a Tool for Characterizing Antibody Binding and Function

Brian J Booth, Madison Belyea, Danielle Wisheart, Daisuke Oka, Brian Best, James C Delaney, Boopathy Ramakrishnan, Gregory J Babcock, Zachary Shriver, Karthik Viswanathan

>SEE POSTER

Leveraging Computational Approaches in Antibody Workflows: Discovery, Design and Engineering

September 17, 2019 | Discovery on target

Leveraging Computational Approaches in Antibody Workflows: Discovery, Design and Engineering

Luke Robinson

A Global Randomized, Double-Blind, Placebo-Controlled Study Evaluating Safety And Efficacy Of Vis410 In Combination With Oseltamivir Versus Oseltamivir Alone In Hospitalized Adults With Influenza A Requiring Oxygen

August 28, 2019 | International Society for Influenza and Respiratory Viruses (ISIRV) 'OPTIONS X' Conference
Schaefers, et. al.

A Global Randomized, Double-Blind, Placebo-Controlled Study Evaluating Safety And Efficacy Of Vis410 In Combination With Oseltamivir Versus Oseltamivir Alone In Hospitalized Adults With Influenza A Requiring Oxygen

Kristi Schaefers, Kristin Narayan, Susan Sloan, David Oldach, other authors

VIS410, A Broad-Spectrum Anti-Influenza A Monoclonal Antibody Neutralized Baloxovir Resistant Influenza A Virus In-Vitro

August 28, 2019 | International Society for Influenza and Respiratory Viruses (ISIRV) 'OPTIONS X' Conference
Narayan, et. al.

VIS410, A Broad-Spectrum Anti-Influenza A Monoclonal Antibody Neutralized Baloxovir Resistant Influenza A Virus In-Vitro

Kristin Narayan, Jeremy Jones, Scott Rich, Elena Govorkova, Susan Sloan, David Oldach

>SEE POSTER

Designing and Engineering Antibodies to Mutable Protein Targets

April 14, 2019 | World Vaccine Congress

Designing and Engineering Antibodies to Mutable Protein Targets

Greg Babcock

Pharmacophore-based Protein Surface Patch Searching and Its Application to in silico Antibody Engineering

April 11, 2019 | PEGS
Bohnuud, et. al.

Pharmacophore-based Protein Surface Patch Searching and Its Application to in silico Antibody Engineering

Tanggis Bohnuud, Andrew Wollacott, Karthik Viswanathan

>SEE POSTER

Antibody Design and Engineering Through Integration of Computational and Experimental Methods

February 26, 2019 | Antibody Engineering & Therapeutics, Asia

Antibody Design and Engineering Through Integration of Computational and Experimental Methods

Karthik Viswanathan

  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • Next Page »

© 2023 Visterra, Inc. Terms of usePrivacy PolicySite Design: Fassino/Design